GlycanAge lands £6.5m in funding led by Fifth Quarter Ventures to bring glycan-based diagnostics into healthcare

GlycanAge develops glycan-based diagnostic tests that help clinicians assess inflammation, ageing and cardiometabolic risk, supporting preventive healthcare and longitudinal monitoring across cardiovascular and female health applications.